You should not start using OPZELURA if you have any kind of infection unless your healthcare provider tells you it is okay. OPZELURA should not be used in people with an active, serious infection, including localized infections. Your healthcare provider should watch you closely for signs and symptoms of TB during treatment with OPZELURA. Some people have had serious infections of their lungs while taking OPZELURA. Some people have been hospitalized or died from these infections. Some people have had serious infections while taking JAK inhibitors by mouth, including tuberculosis (TB), and infections caused by bacteria, fungi, or viruses that can spread throughout the body. JAK inhibitors can lower the ability of your immune system to fight infections. JAK inhibitors are medicines that affect your immune system. Ruxolitinib belongs to a class of medicines called Janus kinase (JAK) inhibitors. Serious Infections: OPZELURA contains ruxolitinib. OPZELURA may cause serious side effects, including: Do not use OPZELURA in your eyes, mouth, or vagina. Incyte reserves the right to rescind, revoke, or amend this offer at any time without notice.įor questions or additional support call 833-613-2333 or email. Incyte may also de-identify the patient’s information and use the de-identified information for Incyte’s business purposes Incyte may also share the patient’s information with its subsidiaries, affiliates, representatives, agents, and contractors. By enrolling in this copay savings program, the patient acknowledges that Incyte may use their information and share it with providers or their insurance plan in connection with providing copay savings support and for the other purposes related to the copay savings program.Data related to the patient’s redemption of the copay savings card may be collected, analyzed, and shared with Incyte or its affiliates for market research and other purposes related to assessing Incyte’s programs.Offer valid only for an FDA-approved use.The copay savings card benefit may not be redeemed more than once per 25 days per patient.This copay savings card is not health insurance.This copay savings card will be accepted only at participating pharmacies.
#Enbrel copay card activation free
Neither the patient, nor the patient’s guardian, pharmacist, or doctor may seek any third-party reimbursement for the value of the copay savings received under this offer.This copay savings card is not valid when the entire cost of the patient’s prescription drug is eligible to be reimbursed by their commercial insurance plan or any other health or pharmacy benefit program.Maximum benefits per tube and per calendar year apply.Individual out-of-pocket cost may vary based on the price at the pharmacy.
Other offers may be available for these patients at other pharmacies Eligible patients whose commercial insurance plan does not cover OPZELURA will pay $35 per prescription and will only be able to redeem this offer at certain participating pharmacies. By using this copay savings card at participating pharmacies, eligible patients with commercial prescription drug insurance coverage for OPZELURA may pay as little as $0 per tube.Offer is not valid for cash-paying patients The patient must have commercial insurance.The patient is not eligible to use this copay savings card if they are enrolled in a state or federally funded prescription insurance program, including, but not limited to, Medicare, Medicaid, TRICARE, Veterans Affairs health care, a state prescription drug assistance program, or the Government Health Insurance Plan available in Puerto Rico (formerly known as “La Reforma de Salud”).
0 kommentar(er)
